Shareholding disclosure

T&D - Trust Directors S.r.l

Declared position

Threshold

Fell below threshold

Timeline

Published

20.02.2021

Transaction

15.02.2021

Transfer date

17.02.2021

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAL2I000A1

Beneficial owner

T&D - Trust Directors S.r.l

Declared address

T&D Trust Directors srl, Milan

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

T&D - Trust Directors S.r.l

IGEA Pharma N.V.20.02.2021TAL2I000A1

Disclosure summary

T&D - Trust Directors S.r.l disclosed a holding in IGEA Pharma N.V. that fell below the publication threshold, published by SIX Exchange Regulation on 20.02.2021, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

T&D - Trust Directors S.r.l disclosed a holding in IGEA Pharma N.V., published on 20.02.2021.

Publication date20.02.2021

Transaction date15.02.2021

Transfer date17.02.2021

Issuing companyIGEA Pharma N.V.

Beneficial ownerT&D - Trust Directors S.r.l

Declared addressT&D Trust Directors srl, Milan

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTAL2I000A1

Source: SIX Exchange Regulation · Publication date: 20.02.2021

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open